EOLSEvolus, Inc.

$338M

Q2 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.12

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$103,000

Balance Sheet

Total Assets

$146M

Total Liabilities

$213M

Stockholders' Equity

-$67M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$2M	-$6M	+62.4%
Net Income	-$2M	-$6M	+62.2%

EOLS Q2 2017 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena